Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Neuroscience Discovery | Whitepapers & Reports

Validation of a Structure-Function Assay for Neurotoxicity in Primary and hiPSC-Derived Neurons

09 June 2022
Comprehensive, high-throughput, in vitro screening of the neurological effects of chemical compounds and drugs is vital for environmental and drug safety
Open document in a new tab

Related Resources

Beyond Traditional Therapeutics: How Digital Therapeutics Reshape Neurological and Neuropsychiatric Treatments

Two case studies show how digital therapeutics can potentially treat neurological and neuropsychiatric conditions, areas where conventional therapeutics have encountered obstacles.
Read More

University of Pennsylvania and FAST to Develop AAV Gene Therapy for Angelman Syndrome

The collaboration hopes to develop a AAV gene therapy for rare genetic disease Angelman syndrome.
Read More

Related Online Activities

Join the conversation with our upcoming Monthly Science Exchanges and Webinars:
01/10/24
Discovery of Novel Therapeutic Modalities